Psoralen regulates bone degenerative diseases by inhibiting APP phosphorylation to regulate MAPK and STAT3 signaling
{{output}}
Background: Psoralen can modulate bone metabolism pathways. This study investigated its effects on bone degenerative diseases, amyloid precursor protein (APP) phosphorylation, and the related pathways. ... ...
